Cedar Street Group is a New York-based venture capital firm that focuses on investing in seed, startup, and early-stage companies within the United States. The firm typically engages in seed and Series B investment rounds, supporting emerging businesses with the capital they need to grow and scale.
Notable portfolio companies include Ceretype Neuromedicine, which has raised $2.15 million, and Medical Metrx Solutions, which has raised $3.5 million. Cedar Street Group is known for its hands-on investment philosophy, providing strategic guidance and leveraging its extensive network to add value to its portfolio companies.
Classification
Headquarters
1890 Palmer Avenue
Suite 203
Larchmont, NY, 10538-3059
US
NAICS
52Finance and InsuranceEdition: 2022
523Securities, Commodity Contracts, and Other Financial Investments and Related ActivitiesEdition: 2022
5239
Other Financial Investment ActivitiesEdition: 2022
52399All Other Financial Investment ActivitiesEdition: 2022